ABRILADA sol inj 40 mg/0.8ml ser pré 0.8 ml
7680678320018
CH-67832
L04AB04
07.15.0.
Reimbursement limitations:
ABRILADA4
Substitution préparation de référence/biosimilaire
Le traitement par ABRILADA exige une garantie préalable de prise en …
1 / 3
google
Details
- Product number
- 6783201
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- adalimumabum 40 mg, histidinum, histidini hydrochloridum monohydricum, dinatrii edetas corresp. natrium 5 µg, saccharum, methioninum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml.
Articles (1)
Abrilada 40 mg / 0.8 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5.0 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 419.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2022
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 67832
- Drug name
- Abrilada, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AB04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 02/12/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ABRILADA sol inj 40 mg/0.8ml ser pré 0.8 ml
- Description (DE)
- ABRILADA Inj Lös 40 mg/0.8ml Fertspr 0.8 ml
- Market launch
- 02/12/2020
- Narcotic (BTM)
- No